Cargando…
CD4(+) T-cell epitope-based heterologous prime-boost vaccination potentiates anti-tumor immunity and PD-1/PD-L1 immunotherapy
BACKGROUND: Antitumor therapeutic vaccines are generally based on antigenic epitopes presented by major histocompatibility complex (MHC-I) molecules to induce tumor-specific CD8(+) T cells. Paradoxically, continuous T cell receptor (TCR) stimulation from tumor-derived CD8(+) T-cell epitopes can driv...
Autores principales: | Xiao, Minglu, Xie, Luoyingzi, Cao, Guoshuai, Lei, Shun, Wang, Pengcheng, Wei, Zhengping, Luo, Yuan, Fang, Jingyi, Yang, Xingxing, Huang, Qizhao, Xu, Lifan, Guo, Junyi, Wen, Shuqiong, Wang, Zhiming, Wu, Qing, Tang, Jianfang, Wang, Lisha, Chen, Xiangyu, Chen, Cheng, Zhang, Yanyan, Yao, Wei, Ye, Jianqiang, He, Ran, Huang, Jun, Ye, Lilin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114852/ https://www.ncbi.nlm.nih.gov/pubmed/35580929 http://dx.doi.org/10.1136/jitc-2021-004022 |
Ejemplares similares
-
PD-1/PD-L1 blockade restores tumor-induced COVID-19 vaccine bluntness
por: Chen, Xiangyu, et al.
Publicado: (2023) -
Tumor-Specific CD4(+) T Cells Restrain Established Metastatic Melanoma by Developing Into Cytotoxic CD4(–) T Cells
por: Liu, Qiao, et al.
Publicado: (2022) -
Bcl6 Preserves the Suppressive Function of Regulatory T Cells During Tumorigenesis
por: Li, Yiding, et al.
Publicado: (2020) -
The Transcription Factor T-Bet Is Required for Optimal Type I Follicular Helper T Cell Maintenance During Acute Viral Infection
por: Wang, Pengcheng, et al.
Publicado: (2019) -
Molecular Basis of the Differentiation and Function of Virus Specific Follicular Helper CD4(+) T Cells
por: Huang, Qizhao, et al.
Publicado: (2019)